JMP Securities Initiates Coverage On Skye Bioscience with Market Outperform Rating, Announces Price Target of $15
Portfolio Pulse from Benzinga Newsdesk
JMP Securities has initiated coverage on Skye Bioscience with a Market Outperform rating and set a price target of $15.
September 10, 2024 | 10:01 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JMP Securities has initiated coverage on Skye Bioscience with a Market Outperform rating and a price target of $15, indicating a positive outlook.
The initiation of coverage with a Market Outperform rating and a $15 price target by JMP Securities suggests a positive outlook for Skye Bioscience. This could lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100